Tomotherapy as a neoadjuvant treatment for locally advanced esophageal cancer might increase bone marrow toxicity in comparison with intensity-modulated radiotherapy and volumetric-modulated arc therapy-Reference-Cited by-同舟云学术

Tomotherapy as a neoadjuvant treatment for locally advanced esophageal cancer might increase bone marrow toxicity in comparison with intensity-modulated radiotherapy and volumetric-modulated arc therapy

Published:2020 Issue:1 Volume:45 Page:e6-e12
ISSN:0958-3947
Container-title:Medical Dosimetry
language:en
Short-container-title:Medical Dosimetry

Author:

Wang Yulong,Xiao Qin,Zeng Biao,Ni Qianxi,Liu Xuewen,Liu Xiaoyang,Tian Lamei,Sheng Cai,Peng Lijuan,Wang Hui

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Radiological and Ultrasound Technology

Reference33 articles.

1. Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer;Allum;J Clin Oncol,2009

2. Long-term results of RTOG trial 8911 (USA Intergroup 113): A random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer;Kelsen;J Clin Oncol,2007

3. The NCCN esophageal and esophagogastric junction cancers clinical practice guidelines in oncology (version 2.2018)[EB/OL]. NCCN; 2018.

4. Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): Long-term results of a randomised controlled trial;Shapiro;Lancet Oncol,2015

5. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer;Kelsen;N Engl J Med,1998

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dosimetric comparison of different radial and longitudinal margins for tomotherapy in esophageal cancer;INT J RADIAT RES;2024

2. Planning evaluation of a novel volume-based algorithm for personalized optimization of lung dose in VMAT for esophageal cancer;Scientific Reports;2022-02-15